• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于新型细胞系的原位异种移植小鼠模型可重现人类肝母细胞瘤。

A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma.

机构信息

Divisions of Pediatric Surgery and Surgical Research, Michael E. DeBakey Department of Surgery, Texas Children's Surgical Oncology Program, Texas Children's Liver Tumor Program, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA.

Department of Pediatrics, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA.

出版信息

Sci Rep. 2017 Dec 19;7(1):17751. doi: 10.1038/s41598-017-17665-8.

DOI:10.1038/s41598-017-17665-8
PMID:29259231
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5736579/
Abstract

Currently, preclinical testing of therapies for hepatoblastoma (HB) is limited to subcutaneous and intrasplenic xenograft models that do not recapitulate the hepatic tumors seen in patients. We hypothesized that injection of HB cell lines into the livers of mice would result in liver tumors that resemble their clinical counterparts. HepG2 and Huh-6 HB cell lines were injected, and tumor growth was monitored with bioluminescence imaging (BLI) and magnetic resonance imaging (MRI). Levels of human α-fetoprotein (AFP) were monitored in the serum of animals. Immunohistochemical and gene expression analyses were also completed on xenograft tumor samples. BLI signal indicative of tumor growth was seen in 55% of HepG2- and Huh-6-injected animals after a period of four to seven weeks. Increased AFP levels correlated with tumor growth. MRI showed large intrahepatic tumors with active neovascularization. HepG2 and Huh-6 xenografts showed expression of β-catenin, AFP, and Glypican-3 (GPC3). HepG2 samples displayed a consistent gene expression profile most similar to human HB tumors. Intrahepatic injection of HB cell lines leads to liver tumors in mice with growth patterns and biologic, histologic, and genetic features similar to human HB tumors. This orthotopic xenograft mouse model will enable clinically relevant testing of novel agents for HB.

摘要

目前,对肝母细胞瘤 (HB) 的治疗方法的临床前测试仅限于皮下和脾内异种移植模型,这些模型不能重现患者中见到的肝肿瘤。我们假设将 HB 细胞系注射到小鼠肝脏中会导致类似于临床对照的肝肿瘤。注射 HepG2 和 Huh-6 HB 细胞系,并通过生物发光成像 (BLI) 和磁共振成像 (MRI) 监测肿瘤生长。监测动物血清中人α-胎蛋白 (AFP) 的水平。还对异种移植肿瘤样本进行了免疫组织化学和基因表达分析。在四到七周的时间后,55%的 HepG2 和 Huh-6 注射动物的 BLI 信号显示出肿瘤生长的迹象。AFP 水平的升高与肿瘤生长相关。MRI 显示出具有活跃新生血管的大肝内肿瘤。HepG2 和 Huh-6 异种移植物显示出β-连环蛋白、AFP 和 Glypican-3 (GPC3) 的表达。HepG2 样本显示出与人类 HB 肿瘤最相似的一致基因表达谱。HB 细胞系的肝内注射会导致小鼠肝肿瘤的生长模式以及生物学、组织学和遗传特征与人类 HB 肿瘤相似。这种原位异种移植小鼠模型将能够对 HB 的新型药物进行临床相关的测试。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edef/5736579/35e2fe9efb05/41598_2017_17665_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edef/5736579/0c01b2867441/41598_2017_17665_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edef/5736579/8979e0e06dce/41598_2017_17665_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edef/5736579/a802ad3c91ea/41598_2017_17665_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edef/5736579/58c34bb31bd6/41598_2017_17665_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edef/5736579/35e2fe9efb05/41598_2017_17665_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edef/5736579/0c01b2867441/41598_2017_17665_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edef/5736579/8979e0e06dce/41598_2017_17665_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edef/5736579/a802ad3c91ea/41598_2017_17665_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edef/5736579/58c34bb31bd6/41598_2017_17665_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edef/5736579/35e2fe9efb05/41598_2017_17665_Fig5_HTML.jpg

相似文献

1
A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma.基于新型细胞系的原位异种移植小鼠模型可重现人类肝母细胞瘤。
Sci Rep. 2017 Dec 19;7(1):17751. doi: 10.1038/s41598-017-17665-8.
2
Subcutaneous and intrahepatic growth of human hepatoblastoma in immunodeficient mice.人肝母细胞瘤在免疫缺陷小鼠体内的皮下及肝内生长
J Hepatol. 2006 Sep;45(3):377-86. doi: 10.1016/j.jhep.2006.03.018. Epub 2006 May 3.
3
Successful establishment of an orthotopic hepatoblastoma in vivo model in NOD/LtSz-scid IL2Rγnull mice.在 NOD/LtSz-scid IL2Rγnull 小鼠体内成功建立了肝母细胞瘤原位模型。
PLoS One. 2011;6(8):e23419. doi: 10.1371/journal.pone.0023419. Epub 2011 Aug 10.
4
Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.肝癌细胞表达截断的神经激肽-1 受体,阿瑞匹坦可在体外和体内抑制其生长。
J Hepatol. 2014 May;60(5):985-94. doi: 10.1016/j.jhep.2013.12.024. Epub 2014 Jan 8.
5
Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer.用于小儿肝癌治疗测试的新型患者来源异种移植模型和细胞系模型
J Hepatol. 2016 Aug;65(2):325-33. doi: 10.1016/j.jhep.2016.04.009. Epub 2016 Apr 23.
6
Antitumor effect of vascular endothelial growth factor inhibitor sunitinib in preclinical models of hepatocellular carcinoma.血管内皮生长因子抑制剂舒尼替尼在肝癌临床前模型中的抗肿瘤作用。
Eur J Gastroenterol Hepatol. 2012 May;24(5):563-74. doi: 10.1097/MEG.0b013e328350916f.
7
In vivo bioluminescent imaging of α-fetoprotein-producing hepatocellular carcinoma in the diethylnitrosamine-treated mouse using recombinant adenoviral vector.利用重组腺病毒载体对二乙基亚硝胺处理的小鼠中产生甲胎蛋白的肝癌进行活体生物发光成像。
J Gene Med. 2012 Aug;14(8):513-20. doi: 10.1002/jgm.2648.
8
mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.mTORC1 通过上调 GP73 促进肝癌细胞的增殖和迁移,并促进小鼠异种移植肿瘤的生长。
Gastroenterology. 2015 Sep;149(3):741-52.e14. doi: 10.1053/j.gastro.2015.05.005. Epub 2015 May 14.
9
Microarray profiling shows distinct differences between primary tumors and commonly used preclinical models in hepatocellular carcinoma.微阵列分析显示,原发性肝癌的原发肿瘤与常用的临床前模型之间存在明显差异。
BMC Cancer. 2015 Oct 31;15:828. doi: 10.1186/s12885-015-1814-8.
10
Establishment of an experimental model of human hepatoblastoma.人肝母细胞瘤实验模型的建立。
Cancer. 1982 Jul 1;50(1):97-101. doi: 10.1002/1097-0142(19820701)50:1<97::aid-cncr2820500118>3.0.co;2-4.

引用本文的文献

1
Lactoferrin targeting INTL1 receptor inhibits hepatocellular carcinoma progression via apoptosis and cell cycle signaling pathways.靶向INTL1受体的乳铁蛋白通过凋亡和细胞周期信号通路抑制肝细胞癌进展。
Sci Rep. 2024 Dec 28;14(1):31210. doi: 10.1038/s41598-024-82514-4.
2
Genomic profiling of subcutaneous patient-derived xenografts reveals immune constraints on tumor evolution in childhood solid cancer.皮下患者来源异种移植物的基因组分析揭示了儿童实体瘤中肿瘤进化对免疫的限制。
Nat Commun. 2023 Nov 22;14(1):7600. doi: 10.1038/s41467-023-43373-1.
3
Advancements of fish-derived peptides for mucormycosis: a novel strategy to treat diabetic compilation.

本文引用的文献

1
Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.儿童肝母细胞瘤的风险分层分期:来自国际儿童肝脏肿瘤协作组的统一分析
Lancet Oncol. 2017 Jan;18(1):122-131. doi: 10.1016/S1470-2045(16)30598-8. Epub 2016 Nov 22.
2
HULC cooperates with MALAT1 to aggravate liver cancer stem cells growth through telomere repeat-binding factor 2.HULC与MALAT1协同作用,通过端粒重复结合因子2加重肝癌干细胞的生长。
Sci Rep. 2016 Oct 26;6:36045. doi: 10.1038/srep36045.
3
Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups.
鱼类来源肽在毛霉病中的研究进展:一种治疗糖尿病合并症的新策略。
Mol Biol Rep. 2023 Dec;50(12):10485-10507. doi: 10.1007/s11033-023-08882-8. Epub 2023 Nov 2.
4
Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma.高危肝母细胞瘤中癌症相关基因和化疗遗传修饰体的全基因组图谱绘制。
Nat Commun. 2023 Jul 6;14(1):4003. doi: 10.1038/s41467-023-39717-6.
5
Ribonucleotide reductase subunit switching in hepatoblastoma drug response and relapse.肝癌药物反应和复发中的核糖核苷酸还原酶亚基转换。
Commun Biol. 2023 Mar 8;6(1):249. doi: 10.1038/s42003-023-04630-7.
6
Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults.具有癌特征的肝母细胞瘤代表了儿童和年轻成人中一组侵袭性强的肿瘤的生物学谱。
J Hepatol. 2022 Oct;77(4):1026-1037. doi: 10.1016/j.jhep.2022.04.035. Epub 2022 May 14.
7
HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells.源自HepT1的高危肝母细胞瘤小鼠模型表现出血管侵袭、转移和循环肿瘤细胞。
Biol Open. 2022 Sep 15;11(9). doi: 10.1242/bio.058973. Epub 2022 Sep 12.
8
Current Approaches in Hepatoblastoma-New Biological Insights to Inform Therapy.当前肝癌治疗方法的新生物学见解。
Curr Oncol Rep. 2022 Sep;24(9):1209-1218. doi: 10.1007/s11912-022-01230-2. Epub 2022 Apr 19.
9
Protocol for chronic hepatitis B virus infection mouse model development by patient-derived orthotopic xenografts.通过患者来源的原位异种移植建立慢性乙型肝炎病毒感染小鼠模型的方案。
PLoS One. 2022 Feb 23;17(2):e0264266. doi: 10.1371/journal.pone.0264266. eCollection 2022.
10
Spatial Lipidomics Reveals Anticancer Mechanisms of Bufalin in Combination with Cinobufagin in Tumor-Bearing Mice.空间脂质组学揭示了蟾毒灵与华蟾酥毒基联合应用于荷瘤小鼠的抗癌机制。
Front Pharmacol. 2021 Jan 12;11:593815. doi: 10.3389/fphar.2020.593815. eCollection 2020.
肝癌的基因组分析确定了不同的分子和预后亚组。
Hepatology. 2017 Jan;65(1):104-121. doi: 10.1002/hep.28888. Epub 2016 Nov 29.
4
Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer.用于小儿肝癌治疗测试的新型患者来源异种移植模型和细胞系模型
J Hepatol. 2016 Aug;65(2):325-33. doi: 10.1016/j.jhep.2016.04.009. Epub 2016 Apr 23.
5
Patient-derived mouse xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management.来源于小儿肝癌患者的小鼠异种移植可预测肿瘤复发并为临床治疗提供指导。
Hepatology. 2016 Oct;64(4):1121-35. doi: 10.1002/hep.28621. Epub 2016 Jun 16.
6
Pediatric hepatoblastoma: diagnosis and treatment.小儿肝母细胞瘤:诊断与治疗。
Transl Pediatr. 2014 Oct;3(4):293-9. doi: 10.3978/j.issn.2224-4336.2014.09.01.
7
The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model.儿童肝肿瘤国际协作组(CHIC):新型全球罕见肿瘤数据库揭示了肝母细胞瘤新的预后因素并成为一种研究模式。
Eur J Cancer. 2016 Jan;52:92-101. doi: 10.1016/j.ejca.2015.09.023. Epub 2015 Dec 1.
8
In vivo tumor growth of high-grade serous ovarian cancer cell lines.高级别浆液性卵巢癌细胞系的体内肿瘤生长情况
Gynecol Oncol. 2015 Aug;138(2):372-7. doi: 10.1016/j.ygyno.2015.05.040. Epub 2015 Jun 5.
9
Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations.不同地理位置肝细胞癌中常见的端粒酶逆转录酶启动子突变
World J Gastroenterol. 2015 Jan 7;21(1):311-7. doi: 10.3748/wjg.v21.i1.311.
10
The genomic landscape of hepatoblastoma and their progenies with HCC-like features.肝母细胞瘤及其具有 HCC 样特征的后代的基因组图谱。
J Hepatol. 2014 Dec;61(6):1312-20. doi: 10.1016/j.jhep.2014.08.009. Epub 2014 Aug 15.